Dishman Pharmaceuticals and Chemicals Ltd Merged Nine Monthly Results

Gross Sales

1,149.3

1,158.91

1,139.73

972.59

922.1

Excise Duty

0

0

0

0

0

Net Sales

1,149.3

1,158.91

1,139.73

972.59

922.1

Other Operating Income

24.72

17.63

11.8

3.31

12.14

Other Income

30.2

10.66

13.28

7.8

6.84

Total Income

1,204.22

1,187.2

1,164.8

983.7

941.09

Total Expenditure

860.39

864.61

913.4

731.27

719.16

PBIDT

343.83

322.59

251.4

252.42

221.92

Interest

54.75

75.43

64.72

67.05

61.58

PBDT

289.08

247.16

186.68

185.38

160.35

Depreciation

88.61

90.57

80.04

79.44

60.47

Minority Interest Before NP

0

0

0

0

0

Tax

49.24

43.25

25.47

19.25

18.19

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

151.23

113.34

81.17

86.68

81.68

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

150.86

112.49

81.2

86.69

81.72

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

150.86

112.49

81.2

86.69

81.72

EPS (Unit Curr.)

9.35

15.02

10.06

10.73

10.11

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

60

0

0

0

0

Equity

32.28

16.14

16.14

16.13

16.13

Public Shareholding (Number)

0

0

3,11,48,667

3,09,26,758

3,11,83,696

Public Shareholding (%)

0

0

38.6

38.31

38.63

Pledged/Encumbered - No. of Shares

0

0

1,77,16,500

1,18,00,000

47,80,000

Pledged/Encumbered - % in Total Promoters Holding

0

0

35.76

23.7

9.64

Pledged/Encumbered - % in Total Equity

0

0

21.95

14.61

5.92

Non Encumbered - No. of Shares

0

0

3,18,31,949

3,79,70,376

44,33,440

Non Encumbered - % in Total Promoters Holding

0

0

64.24

76.29

90.34

Non Encumbered - % in Total Equity

0

0

39.45

47.06

55.43

PBIDTM(%)

29.91

27.83

22.05

25.95

24.06

PBDTM(%)

25.15

21.32

16.37

19.06

17.38

PATM(%)

13.15

9.77

7.12

8.91

8.85